These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23092967)

  • 1. Lessons learned from experimental myocarditis.
    Matsumori A
    Herz; 2012 Dec; 37(8):817-21. PubMed ID: 23092967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulating agents for the management of heart failure with myocarditis and cardiomyopathy--lessons from animal experiments.
    Matsumori A; Sasayama S
    Eur Heart J; 1995 Dec; 16 Suppl O():140-3. PubMed ID: 8682082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons from animal experiments in myocarditis.
    Matsumori A
    Herz; 1992 Apr; 17(2):107-11. PubMed ID: 1349548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of free immunoglobulin light chains on viral myocarditis.
    Matsumori A; Shimada M; Jie X; Higuchi H; Groot Kormelink T; Redegeld FA
    Circ Res; 2010 May; 106(9):1533-40. PubMed ID: 20360247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dilated cardiomyopathy update: infectious-immune theory revisited.
    Kawai C; Matsumori A
    Heart Fail Rev; 2013 Nov; 18(6):703-14. PubMed ID: 23892949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells and autoimmune heart failure.
    Marty RR; Eriksson U
    Int J Cardiol; 2006 Sep; 112(1):34-9. PubMed ID: 16891018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory cardiomyopathy (myocarditis): which patients should be treated with anti-inflammatory therapy?
    Parrillo JE
    Circulation; 2001 Jul; 104(1):4-6. PubMed ID: 11435327
    [No Abstract]   [Full Text] [Related]  

  • 8. Inflammatory dilated cardiomyopathy (DCMI).
    Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
    Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oleanolic acid modulates the immune-inflammatory response in mice with experimental autoimmune myocarditis and protects from cardiac injury. Therapeutic implications for the human disease.
    Martín R; Cordova C; San Román JA; Gutierrez B; Cachofeiro V; Nieto ML
    J Mol Cell Cardiol; 2014 Jul; 72():250-62. PubMed ID: 24732212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of dilated cardiomyopathy: current status and future directions.
    Kawai C
    Cardiovasc Drugs Ther; 1992 Feb; 6(1):7-10. PubMed ID: 1349497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuropeptide cortistatin attenuates experimental autoimmune myocarditis via inhibition of cardiomyogenic T cell-driven inflammatory responses.
    Delgado-Maroto V; Falo CP; Forte-Lago I; Adan N; Morell M; Maganto-Garcia E; Robledo G; O'Valle F; Lichtman AH; Gonzalez-Rey E; Delgado M
    Br J Pharmacol; 2017 Feb; 174(3):267-280. PubMed ID: 27922195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of dilated cardiomyopathies with and without inflammation].
    Hufnagel G; Pankuweit S; Maisch B
    Med Klin (Munich); 1998 Apr; 93(4):240-51. PubMed ID: 9594534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation.
    Cihakova D; Barin JG; Afanasyeva M; Kimura M; Fairweather D; Berg M; Talor MV; Baldeviano GC; Frisancho S; Gabrielson K; Bedja D; Rose NR
    Am J Pathol; 2008 May; 172(5):1195-208. PubMed ID: 18403598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cytokines in autoimmune myocarditis and cardiomyopathy.
    Furukawa Y; Kobuke K; Matsumori A
    Autoimmunity; 2001; 34(3):165-8. PubMed ID: 11908773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin deficiency has no effect in murine autoimmune myocarditis.
    Stroikova V; Fischer A; Bockstahler M; Müller AM; Katus HA; Kaya Z
    Cytokine; 2019 Apr; 116():139-149. PubMed ID: 30716658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically determined myocarditis: clinical presentation and immunological characteristics.
    Caforio AL; Iliceto S
    Curr Opin Cardiol; 2008 May; 23(3):219-26. PubMed ID: 18382209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Myocarditis Treatment Trial: design, methods and patients enrollment.
    Hahn EA; Hartz VL; Moon TE; O'Connell JB; Herskowitz A; McManus BM; Mason JW
    Eur Heart J; 1995 Dec; 16 Suppl O():162-7. PubMed ID: 8682088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies.
    Mascaro-Blanco A; Alvarez K; Yu X; Lindenfeld J; Olansky L; Lyons T; Duvall D; Heuser JS; Gosmanova A; Rubenstein CJ; Cooper LT; Kem DC; Cunningham MW
    Autoimmunity; 2008 Sep; 41(6):442-53. PubMed ID: 18781470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effects of telmisartan against heart failure in rats induced by experimental autoimmune myocarditis through the modulation of angiotensin-converting enzyme-2/angiotensin 1-7/mas receptor axis.
    Sukumaran V; Veeraveedu PT; Gurusamy N; Yamaguchi K; Lakshmanan AP; Ma M; Suzuki K; Kodama M; Watanabe K
    Int J Biol Sci; 2011; 7(8):1077-92. PubMed ID: 21927577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological defects precursors of myocarditis and dilated cardiomyopathy?
    Bolte HD
    J Mol Cell Cardiol; 1985 Jul; 17 Suppl 2():69-71. PubMed ID: 3162035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.